The SP jumped to the $2-3 range on the news Vyera
Post# of 154855
(Total Views: 647)
Posted On: 11/02/2020 9:15:33 AM
The SP jumped to the $2-3 range on the news Vyera HIV partnership news. nothing to do with covid so I don't understand how you think no covid revenue will result in a $.75 SP. Also, the run up to $10 was not in my opinion a result of Dr Patterson. It is easier/possible to dump a SP from $10 to $3 if the run up to $10 was created by those who shorted it from $10 to $3. They saw the opportunity a mile away and got a lot of investors to jump in and then scared them away. The salary's, trial expenses and cost of approvals have always been a part of this company, it is not a charity and it will not succeed if it depends on zero salary's and zero applications and zero trials.
All of this sky falling is also based on your assumption that Leronlimab will not be a covid treatment and it will never be approved in HIV. I think these are both wrong. Also, in the history of this company, they have raised the funds needed in times that were way more difficult than now. There are a large number of investors that are not going to let their investment fail because of lack of funds.
All of this sky falling is also based on your assumption that Leronlimab will not be a covid treatment and it will never be approved in HIV. I think these are both wrong. Also, in the history of this company, they have raised the funds needed in times that were way more difficult than now. There are a large number of investors that are not going to let their investment fail because of lack of funds.
(9)
(0)